Pelthos Therapeutics Files 4/A Amendment
Ticker: PTHS · Form: 4/A · Filed: 2026-04-01T17:39:34-04:00
Sentiment: neutral
Topics: insider-filing, amendment, ownership
TL;DR
Pelthos filed a 4/A amendment on ownership. No new info, just a fix.
AI Summary
Pelthos Therapeutics Inc. filed an amendment (4/A) on April 1, 2026, to a statement of changes in beneficial ownership of securities. The filing pertains to a reportable period ending July 2, 2025. The amendment does not specify any new transactions or changes in holdings but serves to correct or update previously filed information.
Why It Matters
This filing indicates a correction or update to ownership information, which is crucial for transparency in securities trading and regulatory compliance.
Risk Assessment
Risk Level: low — A 4/A filing is an amendment to a previous filing and typically indicates corrections or updates rather than new material events.
Key Numbers
- 0001919246-26-000039 — SEC Accession Number (Unique identifier for the filing)
- 2026-04-01 — Filing Date (Date the amendment was accepted by the SEC)
- 2025-07-02 — Period of Report (The period to which the original filing or amendment pertains)
Key Players & Entities
- Pelthos Therapeutics Inc. (company) — Issuer
- Francis Knuettel II (person) — Reporting Person
- 0001919246-26-000039 (dollar_amount) — SEC Accession Number
- 2026-04-01 (dollar_amount) — Filing Date
- 2025-07-02 (dollar_amount) — Period of Report
FAQ
What is the purpose of this 4/A filing?
The 4/A filing is an amendment to a previous statement of changes in beneficial ownership of securities, indicating corrections or updates to previously reported information.
When was this amendment filed and accepted?
The amendment was filed and accepted on April 1, 2026.
What is the period of report for this filing?
The period of report for this filing is July 2, 2025.
Who is the reporting person mentioned in the filing details?
Francis Knuettel II is listed as the reporting person.
What is the CIK number for Pelthos Therapeutics Inc.?
The CIK number for Pelthos Therapeutics Inc. is 0001919246.
From the Filing
EDGAR Filing Documents for 0001919246-26-000039 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] SEC Accession No. 0001919246-26-000039 Filing Date 2026-04-01 Accepted 2026-04-01 17:39:34 Documents 2 Period of Report 2025-07-02 Document Format Files Seq Description Document Type Size 1 FORM 4/A wk-form4a_1775079571.html 4/A 1 FORM 4/A wk-form4a_1775079571.xml 4/A 6935 2 EX-24 pths-section16_poaxv5xknue.htm EX-24 6913 Complete submission text file 0001919246-26-000039.txt 15540 Mailing Address 205 NEWBURY ST SUITE 204 FRAMINGHAM MA 01701 Business Address Francis Knuettel II ( Reporting ) CIK : 0001433316 (see all company filings) Type: 4/A | Act: 34 | File No.: 001-41964 | Film No.: 26829661 Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422 Pelthos Therapeutics Inc. ( Issuer ) CIK : 0001919246 (see all company filings) EIN. : 863335449 | State of Incorp.: NV | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)